MicroRNAs in Sepsis

Asimina Valsamaki1, Vasileios Vazgiourakis1, Konstantinos Mantzarlis1

  • 1Intensive Care Unit, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece.

Biomedicines
|September 28, 2024
PubMed

Insights

MicroRNAs (miRs) show promise as sensitive and specific biomarkers for sepsis diagnosis and prognosis. These non-coding RNAs offer insights into sepsis mechanisms and potential therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Sepsis is a severe inflammatory condition caused by infections.
  • Current biomarkers for sepsis lack specificity.
  • MicroRNAs (miRs) are non-coding RNAs involved in cellular homeostasis and disease, including sepsis.

Purpose of the Study:

  • To review prominent miRs identified in sepsis.
  • To assess the utility of miRs in sepsis diagnosis, prognosis, and classification.
  • To explore miRs as potential screening tools for specific septic parameters.

Main Methods:

  • Literature overview of studies identifying miRs in septic conditions.
  • Analysis of miRs involved in inflammatory and immune pathways.
  • Investigation of miRs for correlation with infection type, affected organs, and immune pathways (e.g., NF-kB, STAT/JACK).

Main Results:

  • Several miRs, including MIR-146a, MIR-155, MIR-181b, MIR-223-5p, MIR-494-3p, MIR-2055b, MIR-150, and MIR-143, are highlighted as potential diagnostic and prognostic tools.
  • miRs can be used in panels to specify infection type, affected organs, and immune pathways.
  • Co-screening of miRs with long non-coding RNAs (LNCs) is suggested for understanding sepsis progression.

Conclusions:

  • miRs offer enhanced specificity and sensitivity compared to traditional biomarkers for sepsis.
  • miRs are stable, easy to use, and provide valuable insights into sepsis molecular basis and causality.
  • miRs hold potential for improved sepsis diagnosis, prognosis, classification, and therapeutic guidance.